Richter Signs License, Distribution Deal with Bayer HealthCare

By Veronika Gulyas

BUDAPEST--Hungary-based central European pharmaceutical company Richter Gedeon Nyrt. (RICHTER.BU) said Tuesday that it has signed a license and distribution agreement with Bayer HealthCare, part of Germany's Bayer AG (BAYRY).

The deal involves the sales of Bayer's low-dose contraceptive drug under the trademark Lisvy in the European Union and other European countries, as well as parts of Latin America.

Under the terms of the agreement, Richter will make an initial payment upon signing the contract followed by further milestone payments.

Moreover, further sales-related royalties will be payable to Bayer subsequent to the launch of the product.

Richter will also be conducting and funding a post-authorization safety study in line with European Medicines Agency regulations.

The agreement widens the scope of Richter's branded female health-care franchise worldwide, one of the company's key segments, said Chief Executive Erik Bogsch.

Write to Veronika Gulyas at [e-mail]; Twitter: @VeronikaGulyas1

Subscribe to WSJ: http://online.wsj.com?mod=djnwires